Nr1h4 nuclear receptor binding compounds

The present invention relates to compounds according to the general formula (1) which bind to the NR1H4 receptor and act as agonists, antagonists or mixed agonists/antagonists of the NR1H4 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of said...

Full description

Saved in:
Bibliographic Details
Main Authors GAHMAN TIM, CHERUVALLATH ZACH, SAGE CARLTON, DEUSCHLE ULRICH, KIELY JOHN, KREMOSER CLAUS, GIEGRICH KRISTINA, KOBER INGO, OTTE KERSTIN, HANECAK RONNIE, SUD MANISH, KRANZ HARALD, KOGL MANFRED, DNEPROVSKAIA ELENA, HEBERT NORMAND, LEE MATTHEW, BAUER ULRIKE
Format Patent
LanguageEnglish
Published 11.01.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds according to the general formula (1) which bind to the NR1H4 receptor and act as agonists, antagonists or mixed agonists/antagonists of the NR1H4 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and the production of medicaments using said compounds.
Bibliography:Application Number: US20040486748